Covista Beats on Q1, Lifts FY2027 Revenue and EPS Guidance
CVSA sits 48% above its 52-week low of $86.97.
Summary
Covista posted Q1 FY2027 revenue of $511.5 million, up 10.7% year over year, with adjusted EPS of $2.19 versus $1.75 a year ago and adjusted EBITDA margin expanding to 25.6% from 24.2%. Enrollment grew for a 13th straight quarter, led by Walden's 12.8% student gain and 14.1% revenue growth. Management raised FY2027 revenue guidance to $2,060-$2,095 million from $2,050-$2,090 million and adjusted EPS to $9.00-$9.20 from $8.90-$9.15. The quarter also brought a leadership change: CFO Robert Phelan will retire after nearly seven years, staying on until a successor is named, with an active search underway. This follows the August 6 disclosure of FY2026 results that beat guidance and first set the FY2027 outlook now being lifted.
At the time of this announcement, CVSA was trading at $128.76 on NYSE in the Trade & Services sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $86.97 to $152.12. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.